Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter Phase 1/2, Open-Label Study of DCC-3014 to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

NCT03069469 is registered in ClinicalTrials.gov with Deciphera Pharmaceuticals, LLC as lead sponsor.

NCT NCT03069469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03069469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter Phase 1/2, Open-Label Study of DCC-3014 to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor
Lead sponsor
Deciphera Pharmaceuticals, LLC
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
February 16, 2017
Completion date
August 31, 2028
Enrollment
120 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignant neoplasm, giant cell tumor of tendon sheath, pigmented villonodular synovitis, tenosynovial giant cell tumor, tenosynovial giant cell tumor, diffuse